We hypothesize that the loss of tumor suppressor function of RBM10 could be crucial for tumorigenesis at the early stage of LUAD, but during the progression of LUAD, RBM10 deficiency activates anti-tumor immunity. The gene discussed is RBM10; the disease is neoplasm.